GTR 95300639
Bids Are Invited For Acquisition Of Cancer Drugs (Republication Of Fr. 90156/2024), According To Conditions, Quantities, Requirements, Established In This Instrument.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
95300639
Tendering Authority
Subscribe to view
Tender No
90019/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Cancer Drugs (Republication Of Fr. 90156/2024), According To Conditions, Quantities, Requirements, Established In This Instrument.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
25-04-2025
Closed
Work Detail
Acquisition Of Cancer Drugs (Republication Of Fr. 90156/2024), According To Conditions, Quantities, Requirements, Established In This Instrument.. Aflibercepte, Alfaepoetin, Bicalutamide, Carboplatin, Cetuximab, Cyclophosphamide, Cyclophosphamide, Cisplatin, Doceetaxel, Doxorrubicin Hydrochloride, Shybill, Etóposide, Flood, Imatinib Mesylate, Irinotecano, Irinotecano, Irinotecano, Irinotecano Hydrochloride, Letrozole, Leupro -Arrorrelin Acetate, Mesna, Methotrexate, Niglarmab, Nigramab, Octreotide, Octreotide, Octreotide, Olaparibe, Pembrolizumab, Pertuzumab, Femozolomide, Femozolomide, Temozolomide, Trastuzumab, Afflibercepte, Cetuximab, Leupro -Circle Acetate, Niglarmab, Niglarmab, Octreotide, Octreotide, Olaparibe, Pembrolizumab, Pertuzumab, Trastuzumab
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
a9859b86-e068-457f-8aef-ff141f6cf010.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.